State of Alaska Department of Revenue’s Amicus Therapeutics FOLD Stock Holding History

State of Alaska Department of Revenue’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,628	Closed	-$240K	–	2188
2026 Q1	$240K	Hold	16,628	–	–	﹤0.01%	1617
2025 Q4	$236K	Buy	16,628 +639	+4%	+$6.28K	﹤0.01%	1632
2025 Q3	$125K	Buy	+15,989	New	+$114K	﹤0.01%	1642

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

State of Alaska Department of Revenue's FOLD Position: Q2 2026 in Review

State of Alaska Department of Revenue sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 16,628 shares — an estimated $240K sold.

State of Alaska Department of Revenue first reported a position in FOLD in Q3 2025 and held it in 3 quarters. The position peaked at $240K in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

State of Alaska Department of Revenue reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
State of Alaska Department of Revenue sold 16,628 Amicus Therapeutics shares in Q2 2026, an estimated $240K.
State of Alaska Department of Revenue first reported a position in Amicus Therapeutics in Q3 2025 and held it in 3 quarters.
State of Alaska Department of Revenue's Amicus Therapeutics position peaked at $240K in Q1 2026.
1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.